PATHFAST?hs-cTnI-II
Mar 2024
261d
Phc Corporation has submitted 1 FDA 510(k) premarket notifications since 2024, of which 1 received clearance as substantially equivalent to a predicate device.
The company's most frequent device categories include Immunoassay Method, Troponin Subunit . Use the specialty filter in the sidebar to narrow results.